Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 6/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9492218 | 0.87 | CYP3A4 (0.33) | CYP3A4TDP1ALDH1A1TAAR1SLC6A2 | |
| Pyridine SCHEMBL11210161 | 0.80 | GAA (0.33) | CYP3A4TDP1ALDH1A1ALOX12MAPK1 | |
| SCHEMBL301154 | 0.80 | TDP1 (0.39) | CYP3A4TDP1ALDH1A1ALOX15TSHR | |
| SCHEMBL10805698 | 0.79 | CYP3A4 (0.35) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL6288582 | 0.79 | TAAR1 (0.50) | ALDH1A1TAAR1SLC6A3MAOATRPA1 | |
| SCHEMBL10412405 | 0.78 | TDP1 (0.38) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 | |
| SCHEMBL12347960 | 0.78 | TDP1 (0.38) | CYP3A4TDP1ALDH1A1TAAR1SLC6A2 | |
| SCHEMBL8092418 | 0.78 | ACHE (0.38) | TDP1ALDH1A1TSHRSLC6A2SLC6A3 | |
| SCHEMBL7088869 | 0.77 | TAAR1 (0.31) | TDP1ALDH1A1TSHRHSD17B10TAAR1 | |
| SCHEMBL25199092 | 0.76 | TDP1 (0.36) | CYP3A4TDP1TAAR1SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167144-A1 | PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION | Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) | 2023-06-01 | — | — | US | claimed |
| EP-4391765-A1 | ORGANIC LIGHT EMITTING DIODE, DISPLAY DEVICE COMPRISING THE SAME AND COMPOUND | Novaled GmbH (DE) | 2024-06-26 | — | — | EP | disclosed |
| CN-111518145-B | Cyano-bridged metal organic compound with intramolecular magnetic transformation and preparation method and application thereof | 荆楚理工学院 | 2023-06-20 | — | — | CN | disclosed |
| US-20230167144-A1 | PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION | Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) | 2023-06-01 | — | — | US | disclosed |
| EP-2990113-B1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| EP-2990112-B1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| CN-105163853-B | The manufacturing method of cyclic carbonate catalyst for synthesizing | 丸善石油化学株式会社 | 2018-06-12 | — | — | CN | disclosed |
| US-9834536-B2 | Method for producing catalyst for cyclic carbonate synthesis | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-12-05 | — | — | US | disclosed |
| CN-1064967-C | Preparation of arylalkyl phosphines, phosphine oxides or phosphine sulfides | CYTEC CANADA INC (CA) | 2001-04-25 | — | — | CN | disclosed |
| EP-0732336-B1 | Process for the preparation of arylalkyl phosphines, arylalkyl phosphine oxides or arylalkyl phosphine sulfides | CYTEC CANADA INC (CA) | 2000-12-20 | — | — | EP | disclosed |
| CN-1139112-A | Preparation of arylalkyl phosphines, phosphine oxides or phosphine sulfides | CYTEC CANADA INC (CA) | 1997-01-01 | — | — | CN | disclosed |
| EP-0732336-A1 | Process for the preparation of arylalkyl phosphines, arylalkyl phosphine oxides or arylalkyl phosphine sulfides | Cytec Canada Inc. (CA) | 1996-09-18 | — | — | EP | disclosed |
| US-5550295-A | Preparation of arylalkyl phosphines, phosphine oxides or phosphine sulfides | CYTEC TECHNOLOGY CORP. (US) | 1996-08-27 | — | — | US | disclosed |
| US-4668823-A | ARYLDICHLOROPHOSPHINE, TWO GRIGNARDS | UNION CARBIDE CORPORATION (US) | 1987-05-26 | — | — | US | disclosed |
| EP-0003897-B1 | PHOSPHINEGOLD(I)SALTS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | SMITHKLINE BECKMAN CORPORATION (US) | 1983-05-25 | — | — | EP | disclosed |
| US-4257973-A | USING ORGANOPHOSPHORUS-PALLADIUM HALIDE COORDINATION CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-03-24 | — | — | US | disclosed |
| EP-0003897-A1 | Phosphinegold(I)salts, process for their preparation and compositions containing them | SMITHKLINE BECKMAN CORPORATION (US) | 1979-09-05 | — | — | EP | disclosed |
| US-4096250-A | ANTI-ARTHRITIC | SMITHKLINE CORPORATION (US) | 1978-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | CYCS, CA7, CA9 | CYP3A4 349/4885TDP1 4293/4885ALDH1A1 3770/4885 |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | SIK2, SIK3, SIK1 | CYP3A4 2971/4885TDP1 3328/4885ALDH1A1 4167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.